Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

TELEFLEX INCORPORATED

(TFX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Teleflex Incorporated Announces New Data from Real-World Clinical Studies of the UroLift System

07/06/2021 | 06:30am EDT

Teleflex Incorporated announced that new data from real-world clinical studies of the UroLift® System for men with benign prostatic hyperplasia (BPH) will be presented at the 36thEuropean Association of Urology (EAU) 2021 Annual Congress taking place virtually July 8-12. There is increasing interest in the role of Real-World Data (RWD) to supplement data from randomized controlled trials (RCTs) and demonstrate effectiveness in the broad population of patients and health care providers in the real world. Teleflex has invested significantly in RWD and these study results will provide new insights about men treated with the Prostatic Urethral Lift (PUL) procedure using the UroLift System.


© S&P Capital IQ 2021
All news about TELEFLEX INCORPORATED
09/14TELEFLEX INCORPORATED : Announces Large-Scale Analysis of Real-World Healthcare ..
AQ
09/14Teleflex Announces Large-Scale Analysis of Real-World Healthcare Claims Data ..
CI
09/09TELEFLEX INCORPORATED : Unveils the UroLift Advanced Tissue Control (ATC)® Syste..
AQ
09/09Teleflex Unveils the UroLift Advanced Tissue Control System and the UroLift 2..
CI
09/07TELEFLEX INCORPORATED : Raymond James Reinstates Teleflex at Outperform with $44..
MT
09/01Teleflex to Present at the Morgan Stanley 19th Annual Global Healthcare Confe..
GL
08/30TELEFLEX INCORPORATED : New Study Provides Insights into the Biocompatibility an..
AQ
08/30Teleflex Incorporated Announces New Study Provides Insights into the Biocompa..
CI
08/26Teleflex to Present at the Wells Fargo 2021 Virtual Healthcare Conference
GL
08/13TELEFLEX INCORPORATED : Ex-dividend day for
FA
More news
Analyst Recommendations on TELEFLEX INCORPORATED
More recommendations
Financials (USD)
Sales 2021 2 820 M - -
Net income 2021 426 M - -
Net Debt 2021 1 921 M - -
P/E ratio 2021 47,6x
Yield 2021 0,26%
Capitalization 18 045 M 18 045 M -
EV / Sales 2021 7,08x
EV / Sales 2022 6,51x
Nbr of Employees 14 000
Free-Float 97,3%
Chart TELEFLEX INCORPORATED
Duration : Period :
Teleflex Incorporated Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends TELEFLEX INCORPORATED
Short TermMid-TermLong Term
TrendsNeutralNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 12
Last Close Price 385,57 $
Average target price 439,25 $
Spread / Average Target 13,9%
EPS Revisions
Managers and Directors
Liam J. Kelly Chairman, President & Chief Executive Officer
Thomas E. Powell Chief Financial Officer & Executive Vice President
Timothy F. Duffy Chief Information Officer & Vice President
Michelle Fox Chief Medical Officer & Vice President
Gwen Chapman Chief Compliance Officer & Vice President